A recent meta-analysis comparing two anti-VEGF therapies—brolucizumab and aflibercept—for the treatm...

Regeneron, a global biotechnology leader, has acquired Oxular, a UK-based clinical-stage company spe...

Genentech and Roche released compelling 2-year data from the phase 3 Pagoda and Pavilion studies eva...

4D Molecular Therapeutics (4DMT) has released promising topline interim data from Part 1 of the SPEC...

Ocugen has announced that the first patient in its Phase 1 clinical trial for OCU200, a potential tr...

Formycon, in collaboration with its licensing partner Klinge Biopharma, has announced that the Europ...

A new study published online July 19 in Diabetes, Obesity and Metabolism has highlighted significant...

A recent study published in the International Journal of Retina and Vitreous has revealed that the u...

A recent study has identified ophthalmic complications in patients taking semaglutide and tirzepatid...

The U.S. Food and Drug Administration (FDA) has approved ranibizumab injection 100 mg/mL (Susvimo; G...